Spectral Medical Inc. (TSE:EDT – Get Free Report)’s stock price hit a new 52-week high on Wednesday . The stock traded as high as C$0.85 and last traded at C$0.84, with a volume of 196600 shares trading hands. The stock had previously closed at C$0.78.
Spectral Medical Price Performance
The company has a debt-to-equity ratio of 26.03, a current ratio of 0.61 and a quick ratio of 0.45. The company has a market cap of C$230.63 million, a PE ratio of -11.71 and a beta of 0.96. The business’s 50 day moving average is C$0.71 and its 200-day moving average is C$0.60.
Spectral Medical Company Profile
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Further Reading
- Five stocks we like better than Spectral Medical
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- Transportation Stocks Investing
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
